Global Critical Limb Ischemia Treatment Market Size By Treatment, By Devices and By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Global Critical Limb Ischemia Treatment Market Size By Treatment, By Devices and By Geographic Scope And Forecast
Critical Limb Ischemia Treatment Market Size And Forecast
Critical Limb Ischemia Treatment Market size was valued at USD 5.09 USD Billion in 2024 and is projected to reach USD 8.65 Billion by 2031, growing at a CAGR of 7.56% during the forecast period 2024-2031.
Global Critical Limb Ischemia Treatment Market Drivers
The market drivers for the Critical Limb Ischemia Treatment Market can be influenced by various factors. These may include
Elderly Prevalence The market is being driven in large part by the growing prevalence of critical limb ischemia, especially among the elderly. Increasingly, CLI cases are caused by things like smoking, obesity, and diabetes.
Technological Developments in Treatment Options The market is growing because of the improvements in treatment results and decreased need for invasive surgeries brought about by developments in minimally invasive treatments like angioplasty and endovascular therapy.
Growing Geriatric Population The growing number of senior citizens, who are more vulnerable to vascular disorders like CLI, is a major factor propelling the market since it raises the need for available therapies.
Growing Awareness Demand for CLI treatments is being driven by patients’ and healthcare professionals’ increasing knowledge of the illness and the value of early diagnosis and therapy.
Increasing Healthcare Expense As more individuals can now afford cutting-edge CLI therapies, rising healthcare expenditure—especially in developing nations—is driving market expansion.
Government Initiatives and Support The market for CLI treatments is also being driven by supportive government policies, research funding, and projects targeted at enhancing the infrastructure of healthcare facilities.
Partnerships and Collaborations By enabling the creation of new treatment alternatives, partnerships between pharmaceutical companies, research institutes, and healthcare providers are propelling market growth.
Global Critical Limb Ischemia Treatment Market Restraints
Several factors can act as restraints or challenges for the Critical Limb Ischemia Treatment Market. These may include
High Cost of Treatment Some patients’ access to CLI treatments is limited by their cost, particularly for more complex procedures like revascularization and amputation prevention methods, which therefore affects market growth.
Limited Awareness and Diagnosis Patients’ and healthcare professionals’ ignorance of CLI may result in underdiagnoses and postponed treatment, which could impede market expansion.
Strict Regulatory Approval Process Market entry and the development of novel solutions might be delayed by the strict and time-consuming regulatory requirements for new treatments and equipment.
Risk of problems Patients and doctors may choose against some CLI therapies because of the possibility of problems including infection, hemorrhage, or nerve injury, especially surgical procedures.
Hindered Treatment Options Market growth may be hindered by the fact that, particularly in situations of severe disease, there may still be few viable treatment options for CLI despite developments.
Difficulties in Reimbursement Different CLI treatment reimbursement rules and coverage may impact patient access and the adoption of novel therapy by healthcare providers.
Competition from Alternative Therapies Amputation and cautious management are two alternative therapies that can affect the market demand for particular treatments in CLI.
Global Critical Limb Ischemia Treatment Market Segmentation Analysis
The Global Critical Limb Ischemia Treatment Market is Segmented on the basis of Treatment, Devices, and Geography.
Critical Limb Ischemia Treatment Market, By Treatment
Devices
Drugs
Antihypertensive Agents
Antiplatelet Drugs
Antithrombotic Agents
Lipid-lowering Agents
Others
Surgery
Based on Treatment, the market is segmented into Devices, Drugs, and Surgery. According to treatment, it is anticipated that the devices segment will dominate the global market for critical limb ischemia therapy during the forecast period. Stents and other artery-dilating tools effectively widen the artery while protecting its wall. For the treatment of critical limb ischemia, these are the tools that are most used. Due to the low complication rates and outstanding technical success of dilation devices and stents, patients have a better quality of life.
These advantages are probably what might drive the devices segment during the forecast period. The increase in FDA approvals and patient preference for revascularization as the original course of therapy are additional factors contributing to the segment’s dominance. Clinical trials for the TOBA II BTK (Tack Endovascular System in Below the Knee Arteries) optimized balloon angioplasty study have lately shown encouraging results.
Critical Limb Ischemia Treatment Market, By Devices
Embolic Protection Devices
Peripheral Dilatation System
Balloon Dilators
Vascular Stents
Based on Devices, the market is segmented into Embolic Protection Devices and Peripheral Dilatation System. The increase in balloon dilatation procedures and CLI vascular surgery provides for the peripheral dilatation system’s anticipated significant contribution to the devices segment during the forecast period. Leading companies are focusing on developing and releasing cutting-edge peripheral dilatation devices in the critical limb ischemia industry.
According to a June 2022 announcement from Cordis, the world’s leading expert on cardiovascular technologies, individuals will use the Radianz Radial Peripheral System. The PTA Catheter by SABER X RADIANZTM, the Guiding Sheath by BRITE TIP RADIANZTM, to optimize lesion access of the lower extremity, and the Vascular Stent System, SMART RADIANZTM, to preserve patency for long-lasting positive outcomes make up the Peripheral System solution Radianz Radial.
Critical Limb Ischemia Treatment Market, By Geography
North America
Europe
Asia Pacific
Latin America
MEA
Based on Regional Analysis, the Global Critical Limb Ischemia Treatment Market is classified into North America, Europe, Asia Pacific, Latin America, and MEA. North America is expected to dominate the global market for critical limb ischemia therapies in the coming years. The market in the region is expected to grow at a moderate CAGR during the forecast period. Increases in government initiatives, public awareness of CLI and other risk-associated conditions, healthcare spending, disposable income, and local access to cutting-edge technology are all factors contributing to the growth. According to recent research, between 2 million and 3 million Americans have severe limb ischemia.
Key Players
Abbott Laboratories
Cesca Therapeutics Inc.
LimFlow SA
Boston Scientific Corporation
Micro Medical Solutions
Pluristem Therapeutics Inc
Rexgenero Ltd.
Report Scope
REPORT ATTRIBUTES
DETAILS
Study Period
2021-2031
Base Year
2024
Forecast Period
2024-2031
Historical Period
2021-2023
Unit
Value (USD Billion)
Key Companies Profiled
Abbott Laboratories, Cesca Therapeutics Inc., LimFlow SA, Boston Scientific Corporation, Micro Medical Solutions, Pluristem Therapeutics Inc, Rexgenero Ltd.
Segments Covered
By Treatment, By Devices and By Geography.
Customization scope
Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
Table of Content
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
